Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/59986
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to alzheimer's disease |
Autor: | Martín-Moreno, Ana María CSIC; Reigada, David CSIC ORCID; Ramírez, Belén G.; Mechoulam, Raphael; Innamorato, Nadia G.; Cuadrado, Antonio CSIC ORCID; Ceballos, María L. de CSIC ORCID | Fecha de publicación: | 2011 | Editor: | American Society for Pharmacology and Experimental Therapeutics | Citación: | Molecular Pharmacology 79(6): 964-973 (2011) | Resumen: | Microglial activation is an invariant feature of Alzheimer's disease (AD). It is noteworthy that cannabinoids are neuroprotective by preventing β-amyloid (Aβ)-induced microglial activation both in vitro and in vivo. On the other hand, the phytocannabinoid cannabidiol (CBD) has shown anti-inflammatory properties in different paradigms. In the present study, we compared the effects of CBD with those of other cannabinoids on microglial cell functions in vitro and on learning behavior and cytokine expression after Aβ intraventricular administration to mice. CBD, (R)-(+)-[2,3-dihydro-5- methyl-3-(4-morpholinylmethyl) pyrrolo-[1,2,3-d,e]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone [WIN 55,212-2 (WIN)], a mixed CB1/CB 2 agonist, and 1,1-dimethylbutyl-1-deoxy-Δ9- tetrahydrocannabinol [JWH-133 (JWH)], a CB2-selective agonist, concentration-dependently decreased ATP-induced (400 μM) increase in intracellular calcium ([Ca2+]i) in cultured N13 microglial cells and in rat primary microglia. In contrast, 4-[4-(1,1-dimethylheptyl)-2,6- dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-methanol [HU-308 (HU)], another CB2 agonist, was without effect. Cannabinoid and adenosine A2A receptors may be involved in the CBD action. CBD- and WIN-promoted primary microglia migration was blocked by CB1 and/or CB2 antagonists. JWH and HU-induced migration was blocked by a CB2 antagonist only. All of the cannabinoids decreased lipopolysaccharide-induced nitrite generation, which was insensitive to cannabinoid antagonism. Finally, both CBD and WIN, after subchronic administration for 3 weeks, were able to prevent learning of a spatial navigation task and cytokine gene expression in β-amyloid-injected mice. In summary, CBD is able to modulate microglial cell function in vitro and induce beneficial effects in an in vivo model of AD. Given that CBD lacks psychoactivity, it may represent a novel therapeutic approach for this neurological disease. Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics. | URI: | http://hdl.handle.net/10261/59986 | DOI: | 10.1124/mol.111.071290 | Identificadores: | doi: 10.1124/mol.111.071290 issn: 0026-895X |
Aparece en las colecciones: | (IC) Artículos (IIBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
121
checked on 29-mar-2024
SCOPUSTM
Citations
280
checked on 23-mar-2024
WEB OF SCIENCETM
Citations
256
checked on 27-feb-2024
Page view(s)
387
checked on 29-mar-2024
Download(s)
97
checked on 29-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.